^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Vyant Bio

    i
    Other names: Cancer Genetics, Inc. | Cancer Genetics Inc. | Cancer Genetics Italia | Cancer Genetics Inc | Response Genetics Inc. | Response Genetics | Pathwork Diagnostics, Inc. | Pathwork Diagnostics | Predicant Biosciences Inc. | Predicant Biosciences | Biospect | Vyant Bio, Inc. | Vyant Bio Inc | StemoniX | StemoniX, Inc. | StemoniX Inc
    Related tests:
    Evidence
    News
    Evidence Level:
    Sensitive: C4 – Case Studies
    [FGFR2-POC1B fusion-Cholangiocarcinoma-pemigatinib]
    Source:
    J Med Case Rep
    Test:

    Tissue Of Origin Test Kit - FFPE

    Title:
    Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: a case report
    Published date:
    12/15/2023
    Excerpt:
    A 69-year-old Caucasian patient...the diagnosis of intrahepatic cholangiocarcinoma, with differentiation grade G2, was confirmed. Since it was an R0 resection of stage I tumor... DNA extraction from Maxwell® RSC DNA FFPE Kit (Promega), DNA amplification through polymerase chain reaction and analysis through capillary electrophoresis (GenomeLab GeXP of Beckman Coulter), which identified an FGFR2 translocation/fusion (FGFR2-POC1B). A targeted therapy with pemigatinib...Our patient had a durable stable disease...
    DOI:
    10.1186/s13256-023-04231-2